Literature DB >> 5701819

Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.

J L Schulman, M Khakpour, E D Kilbourne.   

Abstract

Antibody specific for viral neuraminidase can be demonstrated in mice following (i) pulmonary infection with influenza virus, (ii) immunization with ultraviolet-in-activated influenza virus, (iii) immunization with isolated neuraminidase of influenza A(2) virus, and (iv) passive immunization with sera of rabbits immunized with isolated A(2) neuraminidase. Neuraminidase antibody produced by any of these methods exerts a profound inhibiting effect on virus replication in the lungs of mice challenged with strains of virus having homologous neuraminidase protein, even in the absence of hemagglutinating inhibiting antibody to the challenge virus, and results in markedly decreased pulmonary virus titers and diminished lung lesions. These observations suggest that antineuraminidase immunity may play a significant role in the protection against influenza virus challenge observed in mice after infection or artificial immunization.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5701819      PMCID: PMC375691     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  Recombination of influenza A viruses of human and animal origin.

Authors:  E D Kolbourne
Journal:  Science       Date:  1968-04-05       Impact factor: 47.728

2.  The effect of antineuraminidase antibody on the elution of influenza virus from cells.

Authors:  J Brown; W G Laver
Journal:  J Gen Virol       Date:  1968-03       Impact factor: 3.891

3.  Serological relationships between the neuraminidases in influenza viruses.

Authors:  C K Paniker
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

4.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus.

Authors:  R G Webster; W G Laver
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

5.  Functional significance of sialidose during influenza virus multiplication.

Authors:  J T Seto; R Rott
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

6.  The induction of broadened (multitypic) immunity with doubly antigenic influenza virus recombinants.

Authors:  E D Kilbourne; J L Schulman
Journal:  Trans Assoc Am Physicians       Date:  1965

7.  Identification in a recombinant influenza virus of structural proteins derived from both parents.

Authors:  W G Laver; E D Kilbourne
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

8.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

9.  Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions.

Authors:  R I Jahiel; E D Kilbourne
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

10.  Changing viral susceptibility of a human cell line in continuous cultivation. I. Production of infective virus in a variant of the Chang conjunctival cell following infection with swine or N-WS influenza viruses.

Authors:  S C WONG; E D KILBOURNE
Journal:  J Exp Med       Date:  1961-01-01       Impact factor: 14.307

View more
  114 in total

1.  Biological and protective properties of immune sera directed to the influenza virus neuraminidase.

Authors:  Stefan J Halbherr; Thomas H Ludersdorfer; Meret Ricklin; Samira Locher; Marianne Berger Rentsch; Artur Summerfield; Gert Zimmer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses.

Authors:  Matthew R Sandbulte; Kim B Westgeest; Jin Gao; Xiyan Xu; Alexander I Klimov; Colin A Russell; David F Burke; Derek J Smith; Ron A M Fouchier; Maryna C Eichelberger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.

Authors:  R Jennings; C W Potter; C McLaren; M Brady
Journal:  J Hyg (Lond)       Date:  1975-12

Review 4.  The evolution of seasonal influenza viruses.

Authors:  Velislava N Petrova; Colin A Russell
Journal:  Nat Rev Microbiol       Date:  2017-10-30       Impact factor: 60.633

5.  The role of humoral immunity in host defence against influenza A infection in mice.

Authors:  J L Virelizier; J S Oxford; G C Schild
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

6.  Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.

Authors:  M Tamura; R G Webster; F A Ennis
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Ability of temperature-sensitive mutants of the recombinant influenza S/N (H2N1) virus to induce immunity to parental (H0N1 and H2N2) viruses.

Authors:  B Dolezalová; E Tuĉková; M Stárek; V Vonka; H Zavadova
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

Review 8.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

9.  Virulence of temperature-sensitive mutants of influenza virus.

Authors:  J S Mackenzie
Journal:  Br Med J       Date:  1969-09-27

Review 10.  Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks.

Authors:  Joel V Chua; Wilbur H Chen
Journal:  Crit Care       Date:  2010-04-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.